Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Bridgepoint Group Plc ( (GB:BPT) ).
Bridgepoint Group plc has repurchased 93,781 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing share buyback programme launched in June 2025. The buyback, executed on 7 January 2026 via on-exchange transactions on the London Stock Exchange at an average price of 294.6599 pence per share, will see all repurchased shares cancelled, incrementally reducing the company’s share count and potentially enhancing earnings per share and capital efficiency for investors.
The most recent analyst rating on (GB:BPT) stock is a Hold with a £279.00 price target. To see the full list of analyst forecasts on Bridgepoint Group Plc stock, see the GB:BPT Stock Forecast page.
Spark’s Take on GB:BPT Stock
According to Spark, TipRanks’ AI Analyst, GB:BPT is a Neutral.
The overall stock score of 54 reflects a combination of strong revenue growth and stable gross margins, offset by concerns over declining net profit margins and increased leverage. Technical indicators suggest a bearish trend, and the high P/E ratio raises valuation concerns. However, recent insider share purchases indicate confidence in the company’s future, which may positively influence market perception.
To see Spark’s full report on GB:BPT stock, click here.
More about Bridgepoint Group Plc
Bridgepoint Group plc is a London-listed investment group operating in the financial services sector, focusing on private equity and related investment activities. The company’s shares trade on the London Stock Exchange, where it actively manages its capital structure through market transactions in its own equity.
Average Trading Volume: 879,186
Technical Sentiment Signal: Buy
Current Market Cap: £2.5B
For a thorough assessment of BPT stock, go to TipRanks’ Stock Analysis page.

